XML 35 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
12 Months Ended
Dec. 31, 2021
Accounting Changes and Error Corrections [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

 

16. RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

 

As previously reported, on June 4, 2021, the audit and finance committee (the “Audit and Finance Committee”) of the board of directors of CPI Aerostructures, Inc. (the “Company”), determined, based on the recommendation of management and in consultation with CohnReznick LLP (“CohnReznick”), then the Company’s independent registered public accounting firm, that the Company’s financial statements which were included in its Annual Report on Form 10-K for the year ended December 31, 2020 and Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020, and September 30, 2020 as filed with the Securities and Exchange Commission (the “SEC”) should no longer be relied upon due to errors in such financial statements relating to the recording and reporting of inventory costing and related internal controls (the “Inventory Costing Errors”) and that management’s reports on the effectiveness of internal control over financial reporting, press releases, and investor communications describing the Company’s financial statements for such periods should no longer be relied upon. The Company’s management identified the Inventory Costing Errors during its inventory testing procedures for the preparation of the Company’s financial statements for the quarterly period ended March 31, 2021. At the time of the June 2021 disclosure, the Company estimated and disclosed that the Inventory Costing Errors were expected to increase 2020 net loss reported on the Annual Report on Form 10-K for the year ended December 31, 2020 by $1.9 million to $2.3 million. The Company has now determined that the Inventory Costing Errors increased 2020 net loss by $2,010,084.

 

The correction of the Inventory Costing Errors resulted in the determination that certain contracts were in a loss position and certain inventory items required additional reserves. The Company re-evaluated the sufficiency of its provisions for loss contracts and inventory reserves that it had previously recorded and concluded that increases to these reserves were required. The insufficient reserves resulting from such reserve increases are referred to as “Additional Inventory Reserves” and “Loss Contract Reserve” and are together referred to as the “Insufficient Reserves.” It was further determined by management that the appropriate starting point for increasing the Insufficient Reserves was during the fourth quarter of 2019.

 

On November 16, 2021, the Audit and Finance Committee determined, based on the analysis and recommendation of management and in consultation with CohnReznick, that the Company’s financial statements as of and for the period ended December 31, 2019 which were included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 should no longer be relied upon due to errors in such financial statements relating to the recording and reporting of the Insufficient Reserves, that, similarly, management’s reports on the effectiveness of internal control over financial reporting, press releases, and investor communications describing the Company’s financial statements for such period should no longer be relied upon, and stated that the Company expected to restate its Annual Report on Form 10-K for the years ended December 31, 2020 and December 31, 2019, and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020, and September 30, 2020 as filed with the SEC (the “Original Forms 10-Q”) by filing the Comprehensive Form 10-K/A.

 

The Company, upon conducting an analysis of the impact of the Insufficient Reserves on previously reported financial results, determined that net loss for the years ended December 31, 2020 and 2019 is $324,231 and $2,189,728, respectively, greater than the net loss reported in the Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

 

Considering both the Inventory Costing Errors and the Insufficient Reserves, the Company determined that the net loss for the years ended December 31, 2020 and 2019 is $2,334,315 and $2,300,083, respectively, greater than the net loss reported in the Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and net loss for the quarters ended March 31, 2020 and June 30, 2020 is $544,836 and $763,730, respectively, greater than the net loss reported in the respective Quarterly Reports on Form 10-Q for such periods and the net income for the quarter ended September 30, 2020 is $24,556 more than the net income reported in the Quarterly Report for such period.

 

The Inventory Costing Errors resulted from software processing and coding errors, inconsistent units of measure being used for quantities ordered and quantities received of certain purchased parts, incorrect accruals to accounting periods of the cost of certain goods received and the Company not having a procedure to address over or under absorbed overhead costs at the end of accounting periods. The Inventory Costing Errors affected the income reported with respect to the Company’s product lines for which revenue is recognized when a product ships to customers, which accounted for approximately 15% of total 2020 revenue (the “Non-POC Contracts”). The Inventory Costing Errors did not affect income reported with respect to the Company’s products for which revenue is recognized over time using percentage of completion accounting (the “POC Contracts”). The Loss Contract Reserve and the Additional Inventory Reserves also only affect the income reported with respect to the Company’s Non-POC Contracts, and do not affect the income reported with respect to the Company’s POC Contracts. The Inventory Costing Errors and the Insufficient Reserves did not affect either prior reported revenue or cash flow for fiscal 2020 and 2019.

 

 

 

Management has considered the effect of the Inventory Costing Errors and the Insufficient Reserves on the Company’s prior conclusions of the adequacy of its internal control over financial reporting and disclosure controls and procedures as of the end of each of the applicable periods. As a result of the Inventory Costing Errors and the Insufficient Reserves, management has determined that a material weakness existed in the Company’s internal control over financial reporting as of the end of the quarterly periods ended March 31, 2020, June 30, 2020, September 30, 2020 and for the years ended December 31, 2020 and 2019. See Part II Item 9A – Controls and Procedures within this Form 10-K for a description of these matters.

 

As a result of the restatement included herein caused by the Inventory Costing Errors and Insufficient Reserves, the Company is reporting herein net loss for the years ended December 31, 2020 and December 31, 2019 which is $2,334,315 and $2,300,083, respectively, greater than the net loss reported in the Original Form 10-K and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, net loss for the quarters ended March 31, 2020 and June 30, 2020 which is $544,836 and $763,730, respectively, greater than the net loss reported in the respective Original Forms 10-Q, and net income for the quarter ended September 30, 2020 which is $24,556 greater than the net income reported in the Original Form 10-Q. The Inventory Costing Errors and the Insufficient Reserves did not affect reported revenue or cash flows for the years ended December 31, 2020 or December 31, 2019, or for the quarters ended March 31, June 30 and September 30, 2020.

 

2020 and 2019 Restatement

 

The following is a discussion of the restatement adjustments that were made to the Company’s previously issued December 31, 2020 and December 31, 2019 consolidated financial statements due to the Inventory Costing Errors, Loss Contract Reserve and Additional Inventory Reserves.

 

(a) Inventory Costing Errors

 

The Company determined that the Inventory Costing Errors resulted in incorrectly reported inventory values and reported income for the annual periods ended December 31, 2020 and December 31, 2019, and the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020. The Inventory Costing Errors were comprised of the following:

 

1) Labor costs for work in process were overstated in the detailed inventory records due to an automated reversing entry not processing correctly;

 

2) A customized IT program to calculate weighted average cost was not tested thoroughly enough, which allowed errors in average cost calculations to occur in certain situations;

 

3) Units of Measure were not consistent between quantities ordered and quantities received for certain classes of purchased parts, which resulted in overstatements of inventory values due to units of measure not being consistent with unit prices on purchase orders to suppliers;

 

4) The cost of goods received which had not yet processed through the Company’s quality inspection process at the time of the period-end accounting closes were not properly accrued to the period financial statements;

 

5) The Company did not have a process to address over-absorbed or under-absorbed overhead costs at the end of each accounting period.

 

(b) Loss Contract Reserve

 

After correcting its financial statements for the Inventory Costing Errors, the Company determined that is was a party to some contracts to deliver product upon which the Company would lose money, and thus the Company’s Loss Contract Reserve was increased accordingly for the year ended December 31, 2020 and December 31, 2019, and for the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020.

 

(c) Additional Inventory Reserves

 

After correcting its financial statements for the Inventory Costing Errors, the Company determined that its inventory required additional reserves to reflect current market value and demand, and thus the Company’s Inventory Reserves were increased accordingly for the year ended December 31, 2020 and December 31, 2019, and for the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020.

 

 

 

(d) Income taxes

 

There were no material tax adjustments to the Company’s Provision for/(benefit from) income taxes or Net deferred tax assets (liabilities) related to the impact of the 2020 and 2019 Restatement.

 

The following tables present the impact of the restatement on the Company’s previously reported financial statements as of December 31, 2020; September 30, 2020; June 30, 2020 and March 31, 2020 and December 31, 2019:

 

 

 

Impact on Consolidated Balance Sheets

The effect of the Restatement described above on the accompanying consolidated balance sheets as of December 31, 2020; September 30, 2020; June 30, 2020; March 31, 2020 and December 31, 20019 are as follows: 

                                         
    Consolidated Balance Sheet as at December 31, 2020  
    As Previously
Reported
    Inventory
Costing
Errors
    Loss Contract
Reserve
    Additional Inventory
Reserve
    As Restated  
ASSETS                              
Current Assets:                                        
Cash   $ 6,033,537      $      $      $     $ 6,033,537  
Accounts receivable, net     4,962,906                               4,962,906  
Contract assets     19,729,638                               19,729,638  
Inventory     9,567,921       (1,875,950 )             (1,305,683 )     6,386,288  
Refundable income taxes     40,000                               40,000  
Prepaid expenses and other current assets     534,857                               534,857  
                                         
Total Current Assets   40,868,859      $ (1,875,950 )        $ (1,305,683 )    $ 37,687,226  
                                         
Operating lease right-of-use assets     4,075,048                               4,075,048  
Property and equipment, net     2,521,742                               2,521,742  
Intangibles, net     250,000                               250,000  
Goodwill     1,784,254                               1,784,254  
Other assets     191,179                               191,179  
                                         
Total Assets     49,691,082     $ (1,875,950 )    $     $ (1,305,683 )   $ 46,509,449  
                                         
Liabilities and Shareholders’ Deficit                                        
Current Liabilities:                                        
Accounts payable   $ 12,092,684                             $ 12,092,684  
Accrued expenses     5,693,518       244,403                       5,937,921  
Contract liabilities     1,650,549                               1,650,549  
Loss reserve     800,971               1,208,276               2,009,247  
Current portion of long-term debt     6,501,666                               6,501,666  
Operating lease liabilities     1,819,237                               1,819,237  
Income taxes payable     862       86                       948  
                                         
Total Current Liabilities     28,559,487       244,489       1,208,276             30,012,252  
                                         
Line of credit     20,738,685                               20,738,685  
Long-term operating lease liabilities     2,537,149                               2,537,149  
Long-term debt, net of current portion     6,205,095                               6,205,095  
                                         
Total Liabilities     58,040,416       244,489       1,208,276             59,493,181  
                                         
Shareholders’ Deficit:                                        
Common stock     11,951                               11,951  
Additional paid-in capital     72,005,841                               72,005,841  
Accumulated deficit     (80,367,126 )     (2,120,439 )   $ (1,208,276 )     (1,305,683 )     (85,001,524 )
Total Shareholders’ Deficit     (8,349,334 )     (2,120,439 )     (1,208,276 )     (1,305,683 )     (12,983,732 )
Total Liabilities and Shareholders’ Deficit   $ 49,691,082     $ (1,875,950 )         $ (1,305,683 )   $ 46,509,449  

 

 

                                         
    Consolidated Balance Sheet as at September 30, 2020  
    As Previously Reported     Inventory
Costing
Errors
    Loss Contract Reserve     Additional Inventory Reserve     As Restated  
ASSETS                              
Current Assets:                                        
Cash   $ 3,589,095      $      $      $     $ 3,589,095  
Restricted cash     1,380,684                               1,380,684  
Accounts receivable, net     7,309,323                               7,309,323  
Contract assets     18,409,267                               18,409,267  
Inventory     8,742,093       (962,577 )             (1,226,852 )     6,552,664  
Refundable income taxes     35,459                               35,459  
Prepaid expenses and other current assets     600,889                               600,889  
                                         
Total Current Assets     40,066,810       (962,577 )           (1,226,852 )     37,877,381  
                                         
Operating lease right-of-use assets     2,730,567                               2,730,567  
Property and equipment, net     2,618,887                               2,618,887  
Intangibles, net     281,250                               281,250  
Goodwill     1,784,254                               1,784,254  
Other assets     205,844                               205,844  
                                         
Total Assets     47,687,612     $ (962,577 )    $     $ (1,226,852 )   $ 45,498,183  
                                         
Liabilities and Shareholders’ Deficit                                        
Current Liabilities:                                        
Accounts payable   $ 13,009,645                             $ 13,009,645  
Accrued expenses     3,333,335       86,467                       3,419,802  
Contract liabilities     2,469,441                               2,469,441  
Loss reserve     1,569,447               1,308,197               2,877,644  
Current portion of long-term debt     5,377,559                               5,377,559  
Operating lease liabilities     1,821,136                               1,821,136  
Income taxes payable     1,216                               1,216  
                                         
Total Current Liabilities     27,581,779       86,467       1,308,197             28,976,443  
                                         
Line of credit     20,738,685                               20,738,685  
Long-term operating lease liabilities     1,212,573                               1,212,573  
Long-term debt, net of current portion     7,811,467                               7,811,467  
                                         
Total Liabilities     57,344,504       86,467       1,308,197             58,739,168  
                                         
Shareholders’ Deficit:                                        
Common stock     11,926                               11,926  
Additional paid-in capital     71,972,011                               71,972,011  
Accumulated deficit     (81,640,829 )     (1,049,044 )   $ (1,308,197 )     (1,226,852 )     (85,224,922 )
Total Shareholders’ Deficit     (9,656,892 )     (1,049,044 )     (1,308,197 )     (1,226,852 )     (13,240,985 )
Total Liabilities and Shareholders’ Deficit   $ 47,687,612     $ (962,577 )         $ (1,226,852 )   $ 45,498,183  

 

 

                                         
    Consolidated Balance Sheet as at June 30, 2020  
    As Previously
Reported
    Inventory Costing
Errors
    Loss Contract
Reserve
    Additional Inventory
Reserve
    As Restated  
ASSETS                              
Current Assets:                                        
Cash   $ 6,749,201      $      $      $     $ 6,749,201  
Restricted cash     1,380,684                               1,380,684  
Accounts receivable, net     6,958,417                               6,958,417  
Contract assets     15,566,681                               15,566,681  
Inventory     7,658,508       (794,960 )             (1,157,695 )     5,705,853  
Refundable income taxes     36,973                               36,973  
Prepaid expenses and other current assets     864,781                               864,781  
                                         
Total Current Assets     39,215,245       (794,960 )           (1,157,695 )     37,262,590  
                                         
Operating lease right-of-use assets     3,122,360                               3,122,360  
Property and equipment, net     2,840,872                               2,840,872  
Intangibles, net     312,500                               312,500  
Goodwill     1,784,254                               1,784,254  
Other assets     123,013                               123,013  
                                         
Total Assets    $ 47,398,244     $ (794,960 )    $     $ (1,157,695 )   $ 45,445,589  
                                         
Liabilities and Shareholders’ Deficit                                        
Current Liabilities:                                        
Accounts payable   $ 9,078,736                             $ 9,078,736  
Accrued expenses     3,825,606       141,638                       3,967,244  
Contract liabilities     4,995,427                               4,995,427  
Loss reserve     2,101,123               1,514,356               3,615,479  
Current portion of long-term debt     4,728,515                               4,728,515  
Operating lease liabilities     1,783,249                               1,783,249  
Income taxes payable     1,216                               1,216  
                                         
Total Current Liabilities     26,513,872       141,638       1,514,356             28,169,866  
                                         
Line of credit     26,738,685                               26,738,685  
Long-term operating lease liabilities     1,680,897                               1,680,897  
Long-term debt, net of current portion     3,077,992                               3,077,992  
                                         
Total Liabilities     58,011,446       141,638       1,514,356             59,667,440  
                                         
Shareholders’ Deficit:                                        
Common stock     11,856                               11,856  
Additional paid-in capital     71,830,980                               71,830,980  
Accumulated deficit     (82,456,038 )     (936,598 )   $ (1,514,356 )     (1,157,695 )     (86,064,687 )
Total Shareholders’ Deficit     (10,613,202 )     (936,598 )     (1,514,356 )     (1,157,695 )     (14,221,851 )
Total Liabilities and Shareholders’ Deficit   $ 47,398,244     $ (794,960 )         $ (1,157,695 )   $ 45,445,589  

 

 

                                         
    Consolidated Balance Sheet as at March 31, 2020  
    As Previously
Reported
    Inventory Costing
Errors
    Loss Contract
Reserve
    Additional Inventory
Reserve
    As Restated  
ASSETS                              
Current Assets:                                        
Cash   $ 1,998,697      $             $ 1,998,697  
Restricted cash     1,380,684                               1,380,684  
Accounts receivable, net     6,107,968                               6,107,968  
Contract assets     15,814,549                               15,814,549  
Inventory     6,940,139       (353,212 )             (1,094,244 )     5,492,683  
Refundable income taxes     473,398                               473,398  
Prepaid expenses and other current assets     688,006                               688,006  
                                         
Total Current Assets     33,403,441       (353,212 )           (1,094,244 )     31,955,985  
                                         
Operating lease right-of-use assets     3,507,760                               3,507,760  
Property and equipment, net     3,061,106                               3,061,106  
Intangibles, net     343,750                               343,750  
Goodwill     1,784,254                               1,784,254  
Other assets     151,041                               151,041  
                                         
Total Assets     42,251,352     $ (353,212 )    $     $ (1,094,244 )   $ 40,803,896  
                                         
Liabilities and Shareholders’ Deficit                                        
Current Liabilities:                                        
Accounts payable   $ 8,255,635                             $ 8,255,635  
Accrued expenses     3,051,727       73,142                       3,124,869  
Contract liabilities     4,749,373                               4,749,373  
Loss reserve     2,145,556               1,324,321               3,469,877  
Current portion of long-term debt     2,460,639                               2,460,639  
Operating lease liabilities     1,745,616                               1,745,616  
Income taxes payable     1,216                               1,216  
                                         
Total Current Liabilities     22,409,762       73,142       1,324,321             23,807,225  
                                         
Line of credit     26,738,685                               26,738,685  
Long-term operating lease liabilities     2,142,574                               2,142,574  
Long-term debt, net of current portion     1,165,905                               1,165,905  
                                         
Total Liabilities     52,456,926       73,142       1,324,321             53,854,389  
                                         
Shareholders’ Deficit:                                        
Common stock     11,837                               11,837  
Additional paid-in capital     71,641,796                               71,641,796  
Accumulated deficit     (81,859,207 )     (426,354 )     (1,324,321 )     (1,094,244 )     (84,704,126 )
Total Shareholders’ Deficit     (10,205,574 )     (426,354 )     (1,324,321 )     (1,094,244 )     (13,050,493 )
Total Liabilities and Shareholders’ Deficit   $ 42,251,352     $ (353,212 )         $ (1,094,244 )   $ 40,803,896  

 

 

                                         
    Consolidated Balance Sheet as at December 31, 2019  
    As Previously
Reported
    Inventory Costing
Errors
    Loss Contract
Reserve
    Additional Inventory
Reserve
    As Restated  
ASSETS                              
Current Assets:                                        
Cash   $ 4,052,109      $      $      $     $ 4,052,109  
Restricted cash     1,380,684                               1,380,684  
Accounts receivable, net     7,029,602                               7,029,602  
Contract assets     15,280,807                               15,280,807  
Inventory     5,891,386       (110,355 )             (874,778 )     4,906,253  
Refundable income taxes     474,904                               474,904  
Prepaid expenses and other current assets     721,964                               721,964  
                                         
Total Current Assets     34,831,456       (110,355 )           (874,778 )     33,846,323  
                                         
Operating lease right-of-use assets     3,886,863                               3,886,863  
Property and equipment, net     3,282,939                               3,282,939  
Intangibles, net     375,000                               375,000  
Goodwill     1,784,254                               1,784,254  
Other assets     179,068                               179,068  
                                         
Total Assets   $ 44,339,580     $ (110,355 )    $     $ (874,778 )   $ 43,354,447  
                                         
Liabilities and Shareholders’ Deficit                                        
Current Liabilities:                                        
Accounts payable   $ 8,199,557                             $ 8,199,557  
Accrued expenses     2,372,522                               2,372,522  
Contract liabilities     3,561,707                               3,561,707  
Loss reserve     2,650,963               1,314,950               3,965,913  
Current portion of long-term debt     2,484,619                               2,484,619  
Operating lease liabilities     1,709,153                               1,709,153  
Income taxes payable     1,216                               1,216  
                                         
Total Current Liabilities     20,979,737             1,314,950             22,294,687  
                                         
Line of credit     26,738,685                               26,738,685  
Long-term operating lease liabilities     2,596,784                               2,596,784  
Long-term debt, net of current portion     1,764,614                               1,764,614  
                                         
Total Liabilities     52,079,820             1,314,950             53,394,770  
                                         
Shareholders’ Deficit:                                        
Common stock     11,819                               11,819  
Additional paid-in capital     71,294,629                               71,294,629  
Accumulated deficit     (79,046,688 )     (110,355 )     (1,314,950 )     (874,778 )     (81,346,771 )
Total Shareholders’ Deficit     (7,740,240 )     (110,355 )     (1,314,950 )     (874,778 )     (10,040,323 )
Total Liabilities and Shareholders’ Deficit   $ 44,339,580     $ (110,355 )         $ (874,778 )   $ 43,354,447  

 

 

 

Impact on Consolidated Statements of Operations

 

The effect of the Restatement described above on the accompanying consolidated statement of operations for the twelve months ended December 31, 2020 is as follows: 

                                         
    Consolidated Statement of Operation For the twelve months ended December 31, 2020  
       
    As Previously Reported     Inventory
Costing
Errors
    Loss Contract Reserve     Inventory Reserve     As Restated  
Revenue   $ 87,584,690      $      $      $     $ 87,584,690  
Cost of sales     75,490,503     $ 2,009,998       (106,674 )     430,905       77,824,732  
Gross profit     12,094,187       (2,009,998 )     106,674       (430,905 )     9,759,958  
Selling, general and administrative expenses     12,046,170                               12,046,170  
Income (loss) from operations     48,017       (2,009,998 )     106,674       (430,905 )     (2,286,212 )
                                         
Other expense:                                        
Interest expense     (1,421,955 )                             (1,421,955 )
Loss before provision for income taxes     (1,373,938 )     (2,009,998 )     106,674       (430,905 )     (3,708,167 )
                                         
Benefit from income taxes     (53,500 )     86                   (53,414 )
Net loss   $ (1,320,438 )   $ (2,010,084 )   $ 106,674     $ (430,905 )   $ (3,654,753 )
Loss per common share - basic   $ (0.11 )   $ (0.17 )   $ 0.01     $ (0.04 )   $ (0.31 )
Loss per common share - diluted   $ (0.11 )   $ (0.17 )   $ 0.01     $ (0.04 )     (0.31 )
Basic     11,884,307                         11,884,307  
Diluted     11,884,307                         11,884,307  

 

 

 

The effect of the Restatement described above on the accompanying consolidated statement of operations for the three and nine months ended September 30, 2020 is as follows: 

                                         
    Consolidated Statement of Operation For the three months ended September 30, 2020 (Unaudited)  
       
    As Previously
Reported
    Inventory Costing
Errors
    Loss Contract
Reserve
    Inventory Reserve     As Restated  
Revenue   $ 25,576,718      $      $      $     $ 25,576,718  
Cost of sales     21,394,243       112,446       (206,159 )     69,157       21,369,687  
Gross profit     4,182,475       (112,446 )     206,159       (69,157 )     4,207,031  
Selling, general and administrative expenses     3,050,644                               3,050,644  
Income from operations     1,131,831       (112,446 )     206,159       (69,157 )     1,156,387  
                                         
Other expense:                                        
Interest expense     (309,008 )                             (309,008 )
Income before provision for income taxes     822,823       (112,446 )     206,159       (69,157 )     847,379  
                                         
Provision for income taxes     7,614                         7,614  
Net Income   $ 815,209     $ (112,446 )   $ 206,159     $ (69,157 )   $ 839,765  
Income per common share - basic   $ 0.07     $ (0.01 )   $ 0.02     $ (0.01 )   $ 0.07  
Income per common share - diluted   $ 0.07     $ (0.01 )   $ 0.02     $ (0.01 )   $ 0.07  
Basic     11,894,469                         11,894,469  
Diluted     11,894,469                         11,917,149  

 

 

                                         
    Consolidated Statement of Operation For the nine months ended September 30, 2020 (Unaudited)  
    As Previously Reported     Inventory
Costing
Errors
    Loss Contract
Reserve
    Inventory Reserve     As Restated  
Revenue   $ 62,175,872      $      $     $     $ 62,175,872  
Cost of sales     54,715,508       938,689       (6,753 )     352,074       55,999,518  
Gross profit     7,460,364       (938,689 )     6,753       (352,074 )     6,176,354  
Selling, general and administrative expenses     8,958,986                               8,958,986  
Loss from operations     (1,498,622 )     (938,689 )     6,753       (352,074 )     (2,782,632 )
                                         
Other expense:                                        
Interest expense     (1,085,805 )                             (1,085,805 )
Loss before provision for income taxes     (2,584,427 )     (938,689 )     6,753       (352,074 )     (3,868,437 )
                                         
Provision for income taxes     9,714                         9,714  
Net loss   $ (2,594,141 )   $ (938,689 )   $ 6,753     $ (352,074 )   $ (3,878,151 )
Loss per common share - basic   $ (0.22 )   $ (0.08 )   $ 0.00     $ (0.03 )   $ (0.33 )
Loss per common share - diluted   $ (0.22 )   $ (0.08 )   $ 0.00     $ (0.03 )     (0.33 )
Basic     11,862,506                         11,862,506  
Diluted     11,862,506                         11,862,506  

 

 

 

The effect of the Restatement described above on the accompanying consolidated statement of operations for the three and six months ended June 30, 2020 is as follows: 

                                         
    Consolidated Statement of Operation For the three months ended June 30, 2020 (Unaudited)  
       
    As Previously Reported     Inventory
Costing
Errors
    Loss Contract Reserve     Inventory Reserve     As Restated  
Revenue   $ 19,740,767     $      $         $ 19,740,767  
Cost of sales     17,160,698     $ 510,244       190,035       63,451       17,924,428  
Gross profit     2,580,069       (510,244 )     (190,035 )     (63,451 )     1,816,339  
Selling, general and administrative expenses     2,815,252                               2,815,252  
Loss from operations     (235,183 )     (510,244 )     (190,035 )     (63,451 )     (998,913 )
                                         
Other expense:                                        
Interest expense     (360,126 )                             (360,126 )
Profit before provision for income taxes     (595,309 )     (510,244 )     (190,035 )     (63,451 )     (1,359,039 )
                                         
Provision for income taxes     1,522                         1,522  
Net profit   $ (596,831 )   $ (510,244 )   $ (190,035 )   $ (63,451 )   $ (1,360,561 )
Loss per common share - basic   $ (0.05 )   $ (0.04 )   $ (0.02 )   $ (0.00 )   $ (0.11 )
Loss per common share - diluted   $ (0.05 )   $ (0.04 )   $ (0.02 )   $ (0.00 )     (0.11 )
Basic     11,855,404                         11,855,404  
Diluted     11,855,404                         11,855,404  

 

                                         
    Consolidated Statement of Operation For the six months ended June 30, 2020 (Unaudited)  
       
    As Previously
Reported
    Inventory Costing
Errors
    Loss Contract
Reserve
    Inventory Reserve     As Restated  
Revenue   $ 36,599,154      $          $     $ 36,599,154  
Cost of sales     33,321,265       826,243       199,406       282,917       34,629,831  
Gross profit     3,277,889       (826,243 )     (199,406 )     (282,917 )     1,969,323  
Selling, general and administrative expenses     5,908,342                               5,908,342  
Loss from operations     (2,630,453 )     (826,243 )     (199,406 )     (282,917 )     (3,939,019 )
                                         
Other expense:                                        
Interest expense     (776,797 )                             (776,797 )
Loss before provision for income taxes     (3,407,250 )     (826,243 )     (199,406 )     (282,917 )     (4,715,816 )
                                         
Provision for income taxes     2,100                         2,100  
Net loss   $ (3,409,350 )   $ (826,243 )   $ (199,406 )   $ (282,917 )   $ (4,717,916 )
Loss per common share - basic   $ (0.29 )   $ (0.07 )   $ (0.02 )   $ (0.02 )   $ (0.40 )
Loss per common share - diluted   $ (0.29 )   $ (0.07 )   $ (0.02 )   $ (0.02 )     (0.40 )
Basic     11,846,260                         11,846,260  
Diluted     11,846,260                         11,846,260  

 

 

 

The effect of the Restatement described above on the accompanying consolidated statement of operations for the three months ended March 31, 2020 is as follows: 

                                         
    Consolidated Statement of Operation For the three months ended March 31, 2020 (Unaudited)  
       
    As Previously Reported     Inventory
Costing
Errors
    Loss Contract Reserve     Inventory Reserve     As Restated  
Revenue   $ 16,858,386      $      $     $     $ 16,858,386  
Cost of sales     16,160,567       315,999       9,371       219,466       16,705,403  
Gross profit     697,819       (315,999 )     (9,371 )     (219,466 )     152,983  
Selling, general and administrative expenses     3,093,090                               3,093,090  
Loss from operations     (2,395,271 )     (315,999 )     (9,371 )     (219,466 )     (2,940,107 )
                                         
Other expense:                                        
Interest expense     (416,670 )                             (416,670 )
Loss before provision for income taxes     (2,811,941 )     (315,999 )     (9,371 )     (219,466 )     (3,356,777 )
                                         
Provision for income taxes     578                         578  
Net loss   $ (2,812,519 )   $ (315,999 )   $ (9,371 )   $ (219,466 )   $ (3,357,355 )
Loss per common share - basic   $ (0.24 )   $ (0.03 )   $ (0.00 )   $ (0.02 )   $ (0.29 )
Loss per common share - diluted   $ (0.24 )   $ (0.03 )   $ (0.00 )   $ (0.02 )     (0.29 )
Basic     11,837,014                         11,837,014  
Diluted     11,837,014                         11,837,014  

 

 

 

The effect of the Restatement described above on the accompanying consolidated statement of operations for the twelve months ended December 31, 2019 is as follows: 

                                         
    Consolidated Statement of Operation For the twelve months ended December 31, 2019
     
    As Previously Reported   Inventory
Costing
Errors
  Loss Contract Reserve   Inventory Reserve   As Restated
Revenue   $ 87,518,688      $             $ 87,518,688  
Cost of sales     78,386,997       110,355       1,314,950       874,778       80,687,080  
Gross profit     9,131,691       (110,355 )     (1,314,950 )     (874,778 )     6,831,608  
Selling, general and administrative expenses     11,562,781                               11,562,781  
Loss from operations     (2,431,090 )     (110,355 )     (1,314,950 )     (874,778 )     (4,731,173 )
                                         
Other income (expense):                                        
Other income     89,666                               89,666  
Interest expense     (2,104,851 )                             (2,104,851 )
Loss before provision for income taxes     (4,446,275 )     (110,355 )     (1,314,950 )     (874,778 )     (6,746,358 )
                                         
Provision for income taxes     3,877                         3,877  
Net loss   $ (4,450,152 )   $ (110,355 )   $ (1,314,950 )   $ (874,778 )   $ (6,750,235 )
Loss per common share - basic   $ (0.38 )   $ (0.01 )   $ (0.11 )   $ (0.07 )   $ (0.57 )
Loss per common share - diluted   $ (0.38 )   $ (0.01 )   $ (0.11 )   $ (0.07 )   $ (0.57 )
Basic     11,808,052                         11,808,052  
Diluted     11,808,052                         11,808,052  

 

 

 

Cumulative Effect of Prior Period Adjustments 

The following table presents the impact of the Restatement on the Company’s shareholders’ deficit as of December 31, 2019 (as restated) and December 31, 2020 (as restated):

 

    Common Stock Shares   Common Stock   Additional
Paid-in Capital
  Accumulated Deficit   Total Shareholders’ Deficit

Balance, December 31, 2019 
(As previously reported) 
 

    11,818,830     $ 11,819     $ 71,294,629     $ (79,046,688 )   $ (7,740,240 )
Inventory Costing Errors                       (110,355 )     (110,355 )
Loss Contract Reserve                       (1,314,950 )     (1,314,950 )
Inventory Reserve                       (874,778 )     (874,778 )
Cumulative restatement adjustments                       (2,300,083 )     (2,300,083 )

Balance, December 31, 2019 
(As Restated) 

    11,818,830     $ 11,819     $ 71,294,629     $ (81,346,771 )   $ (10,040,323 )
                                         
Net Loss (as previously reported)                           $ (2,812,519 )   $ (2,812,519 )
Inventory Costing Errors                       (315,999 )     (315,999 )
Loss Contract Reserve                       (9,371 )     (9,371 )
Inventory Reserve                       (219,466 )     (219,466 )
Cumulative restatement adjustments                       (544,836 )     (544,836 )
Net Loss (as restated)                             (3,357,355 )     (3,357,355 )

Balance, March 31, 2020 
(As Restated) 

    11,837,218     $ 11,837     $ 71,641,796     $ (84,704,126 )   $ (13,050,493 )
Net Loss (as previously reported)                           $ (596,831 )   $ (596,831 )
Inventory Costing Errors                       (510,244 )     (510,244 )
Loss Contract Reserve                       (190,035 )     (190,035 )
Inventory Reserve                       (63,451 )     (63,451 )
Cumulative restatement adjustments                       (763,730 )     (763,730 )
Net Loss (as restated)                             (1,360,561 )     (1,360,561 )
Stock-based compensation     18,388       19       189,184             189,203  

Balance, June 30, 2020 
(As Restated) 
 

    11,855,606     $ 11,856     $ 71,830,980     $ (86,064,687 )   $ (14,221,851 )
                                         
Net Income (as previously reported)                           $ 815,209     $ 815,209  
Inventory Costing Errors                       (112,446 )     (112,446 )
Loss Contract Reserve                       206,159       206,159  
Inventory Reserve                       (69,157 )     (69,157 )
Cumulative restatement adjustments                       24,556       24,556  
Net Income (as restated)                             839,765       839,765  
Stock-based compensation     70,571       70       141,031             141,101  

Balance, September 30, 2020 
(As Restated) 

    11,926,177     $ 11,926     $ 71,972,011     $ (85,224,922 )   $ (13,240,985 )
                                         
Net Income                           $ 1,273,703     $ 1,273,703  
Inventory Costing Errors                       (1,071,395 )     (1,071,395 )
Loss Contract Reserve                       99,921       99,921  
Inventory Reserve                       (78,831 )     (78,831 )
Cumulative restatement adjustments                       (1,050,305 )     (1,050,305 )
Net income (as restated)                             223,398       223,398  
Stock-based compensation     25,094       25       33,830             33,855  

Balance, December 31, 2020 
(As Restated) 
 

    11,951,271     $ 11,951     $ 72,005,841     $ (85,001,524 )   $ (12,983,732 )

 

 

 

Impact on Consolidated Statement of Cash Flows 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the twelve months ended December 31, 2020 is as follows: 

                                         
    Consolidated Statements of Cash Flows for the twelve months
ended December 31, 2020
 
    As
Previously
Reported
    Inventory
Costing
Errors
    Loss
Contract
Reserve
    Inventory
Reserve
    As Restated  
Cash flows from operating activities:                                        
  Net Loss   $ (1,320,438 )   $ (2,010,084 )   $ 106,674     $ (430,905 )   $ (3,654,753 )
Adjustments to reconcile net loss to net cash used in operating activities:                                        
    Depreciation and amortization     1,032,986                               1,032,986  
    Amortization of debt issuance cost     95,429                               95,429  
    Cash expended in excess of rent expense     (137,737 )                             (137,737 )
    Stock-based compensation expense     711,344                               711,344  
    Bad debt expense     (23,395 )                             (23,395 )
Changes in operating assets and liabilities:                                        
   Decrease in accounts receivable     2,090,091                               2,090,091  
   Increase in contract assets     (4,448,831 )                             (4,448,831 )
   Increase in inventory     (3,676,535 )     1,765,595               430,905       (1,480,035 )
 Decrease in prepaid expenses and other current assets     187,107                               187,107  
   Decrease in refundable income taxes     434,904                               434,904  
 Increase in accounts payable and accrued expenses     7,214,124       244,403                       7,458,527  
   Decrease in contract liabilities     (1,911,158 )                             (1,911,158 )
   Decrease in loss reserve     (1,849,992 )             (106,674 )             (1,956,666 )
   Decrease in income taxes payable     (354 )     86                       (268 )
Net cash used in operating activities     (1,602,455 )                       (1,602,455 )
Cash flows from investing activities:                                        
    Purchase of property and equipment     (146,788 )                       (146,788 )
Net cash used in investing activities     (146,788 )                       (146,788 )
Cash flows from financing activities:                                        
    Proceeds from PPP loan     4,795,000                               4,795,000  
    Payments on long-term debt     (2,337,473 )                             (2,337,473 )
   Debt issuance costs     (107,540 )                             (107,540 )
Net cash provided by financing activities     2,349,987                         2,349,987  
Net increase in cash and restricted cash     600,744                         600,744  
Cash and restricted cash at beginning of year     5,432,793                         5,432,793  
Cash and restricted cash at end of year   $ 6,033,537     $     $     $     $ 6,033,537  
Supplemental schedule of noncash investing activities:                                        
Equipment acquired under capital lease   $ 134,900     $     $     $     $ 134,900  
Supplemental schedule of cash flow information:                                        
Cash paid during the year for interest   $ 1,490,152     $     $     $     $ 1,490,152  
Cash (received) from income taxes   $ (488,052 )   $     $     $     $ (488,052 )

 

 

 

Impact on Consolidated Statement of Cash Flows

 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the nine months ended September 30, 2020 is as follows: 

                                         
    Consolidated Statements of Cash Flows for the nine months
ended September 30, 2020 (Unaudited)
 
    As
Previously
Reported
    Inventory
Costing
Errors
    Loss
Contract
Reserve
    Inventory
Reserve
    As Restated  
Cash flows from operating activities:                                        
  Net Loss   $ (2,594,141 )   $ (938,689 )   $ 6,753     $ (352,074 )   $ (3,878,151 )
Adjustments to reconcile net loss to net cash used in operating activities:                                        
    Depreciation and amortization     769,690                               769,690  
    Amortization of debt issuance cost     80,764                               80,764  
    Cash expended in excess of rent expense     (115,932 )                             (115,932 )
    Stock-based compensation expense     677,489                               677,489  
    Bad debt expense     (47,410 )                             (47,410 )
Changes in operating assets and liabilities:                                        
   Increase in accounts receivable     (232,310 )                             (232,310 )
   Increase in contract assets     (3,128,460 )                             (3,128,460 )
   Increase in inventory     (2,850,707 )     852,222               352,074       (1,646,411 )
 Decrease in prepaid expenses and other current assets     121,075                               121,075  
   Decrease in refundable income taxes     439,445                               439,445  
 Increase in accounts payable and accrued expenses     5,770,902       86,467                       5,857,369  
   Decrease in contract liabilities     (1,092,266 )                             (1,092,266 )
   Decrease in loss reserve     (1,081,516 )             (6,753 )             (1,088,269 )
Net cash used in operating activities     (3,283,377 )                                (3,283,377 )
Cash flows from investing activities:                                        
    Purchase of property and equipment     (11,888 )                             (11,888 )
Net cash used in investing activities     (11,888 )                             (11,888 )
Cash flows from financing activities:                                        
    Proceeds from PPP loan     4,795,000                               4,795,000  
    Payments on long-term debt     (1,855,209 )                             (1,855,209 )
   Debt issuance costs     (107,540 )                             (107,540 )
Net cash provided by financing activities     2,832,251                               2,832,251  
Net decrease in cash and restricted cash     (463,014 )                             (463,014 )
Cash and restricted cash at beginning of year     5,432,793                               5,432,793  
Cash and restricted cash at end of year   $ 4,969,779     $        $        $        $ 4,969,779  
Supplemental schedule of cash flow information:                                        
Cash paid during the year for interest   $ 1,156,126     $        $        $        $ 1,156,126  
Cash (received) from income taxes   $ (449,749 )   $        $        $        $ (449,749 )

 

 

 

Impact on Consolidated Statement of Cash Flows

 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the six months ended June 30, 2020 is as follows: 

                                         
    Consolidated Statements of Cash Flows for the six months ended June 30, 2020 (Unaudited)  
    As
Previously
Reported
    Inventory
Costing
Errors
    Loss
Contract
Reserve
    Inventory
Reserve
    As Restated  
Cash flows from operating activities:                                        
  Net Loss   $ (3,409,350 )   $ (826,243 )   $ (199,406 )   $ (282,917 )   $ (4,717,916 )
Adjustments to reconcile net loss to net cash used in operating activities:                                        
    Depreciation and amortization     512,567                               512,567  
    Amortization of debt issuance cost     56,055                               56,055  
    Cash expended in excess of rent expense     (77,288 )                             (77,288 )
    Stock-based compensation expense     536,388                               536,388  
    Bad debt expense     (73,352 )                             (73,352 )
Changes in operating assets and liabilities:                                        
   Decrease in accounts receivable     144,537                               144,537  
   Increase in contract assets     (285,875 )                             (285,875 )
   Increase in inventory     (1,767,122 )     684,605               282,917       (799,600 )
 Increase in prepaid expenses and other current assets     (142,816 )                             (142,816 )
   Decrease in refundable income taxes     437,931                               437,931  
 Increase in accounts payable and accrued expenses     2,332,263       141,638                       2,473,901  
   Decrease in contract liabilities     1,433,720                               1,433,720  
   Decrease in loss reserve     (549,840 )             199,406               (350,434 )
Net cash used in operating activities     (852,182 )                                (852,182 )
Cash flows from investing activities:                                        
    Purchase of property and equipment     (8,000 )                             (8,000 )
Net cash used in investing activities     (8,000 )                             (8,000 )
Cash flows from financing activities:                                        
    Proceeds from PPP loan     4,795,000                               4,795,000  
    Payments on long-term debt     (1,237,726 )                             (1,237,726 )
Net cash provided by financing activities     3,557,274                               3,557,274  
Net increase in cash and restricted cash     2,697,092                               2,697,092  
Cash and restricted cash at beginning of year     5,432,793                               5,432,793  
Cash and restricted cash at end of year   $ 8,129,885     $        $        $        $ 8,129,885  
Supplemental schedule of cash flow information:                                        
Cash paid during the year for interest   $ 845,962     $        $        $        $ 845,962  
Cash (received) from income taxes   $ (449,749 )   $        $        $        $ (449,749 )

 

 

 

Impact on Consolidated Statement of Cash Flows

 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the three months ended March 31, 2020 is as follows: 

                                         
    Consolidated Statements of Cash Flows for the three months
ended March 31, 2020 (Unaudited)
 
    As
Previously
Reported
    Inventory
Costing
Errors
    Loss
Contract
Reserve
    Inventory
Reserve
    As Restated  
Cash flows from operating activities:                                        
  Net Loss   $ (2,812,519 )   $ (315,999 )   $ (9,371 )   $ (219,466 )   $ (3,357,355 )
Adjustments to reconcile net loss to net cash used in operating activities:                                        
    Depreciation and amortization     256,284                               256,284  
    Amortization of debt issuance cost     35,437                               35,437  
    Amortization of right of use asset     (38,644 )                             (38,644 )
    Stock-based compensation expense     347,185                               347,185  
    Bad debt expense     (51,369 )                             (51,369 )
Changes in operating assets and liabilities:                                        
   Decrease in accounts receivable     973,002                               973,002  
   Increase in contract assets     (533,743 )                             (533,743 )
   Increase in inventory     (1,048,752 )     242,857               219,466       (586,429 )
 Decrease in prepaid expenses and other current assets     26,549                               26,549  
   Decrease in refundable income taxes     1,506                               1,506  
 Increase in accounts payable and accrued expenses     735,282       73,142                       808,424  
   Increase in contract liabilities     1,187,667                               1,187,667  
   Decrease in loss reserve     (505,407 )             9,371               (496,036 )
Net cash used in operating activities     (1,427,522 )                                (1,427,522 )
Cash flows from investing activities:                                        
    Purchase of property and equipment     (3,200 )                             (3,200 )
Net cash used in investing activities     (3,200 )                             (3,200 )
Cash flows from financing activities:                                        
    Payments on long-term debt     (622,690 )                             (622,690 )
   Debt issuance costs                                          
Net cash used in financing activities     (622,690 )                             (622,690 )
Net decrease in cash and restricted cash     (2,053,412 )                             (2,053,412 )
Cash and restricted cash at beginning of year     5,432,793                               5,432,793  
Cash and restricted cash at end of period   $ 3,379,381     $        $        $        $ 3,379,381  
Supplemental schedule of cash flow information:                                        
Cash paid during the year for interest   $ 450,191     $        $        $        $ 450,191  
Cash (received) from income taxes   $ (928 )   $        $        $        $ (928 )

 

 

 

Impact on Consolidated Statement of Cash Flows

 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the twelve months ended December 31, 2019 is as follows: 

                     
   Consolidated Statements of Cash Flows for the twelve months ended December 31, 2019 
   As
Previously
Reported
   Inventory
Costing
Errors
   Loss
Contract
Reserve
   Inventory
Reserve
   As Restated 
Cash flows from operating activities:                         
  Net Loss  $(4,450,152)  $(110,355)  $(1,314,950)  $(874,778)  $(6,750,235)
Adjustments to reconcile net loss to net cash used in operating activities:                         
    Depreciation and amortization   1,124,063                   1,124,063 
    Amortization of debt issuance cost   95,507                   95,507 
    Cash expended in excess of rent expense   (112,048)                  (112,048)
  Stock-based compensation expense   730,564                   730,564 
  Common Stock Issued as Employee Compensation   32,324                   32,324 
    Bad debt expense   34,098                   34,098 
Changes in operating assets and liabilities:                         
   Decrease in accounts receivable   1,807,802                   1,807,802 
   Decrease in contract assets   2,308,059                   2,308,059 
   Decrease in inventory   227,336    110,355         874,778    1,212,469 
 Decrease in prepaid expenses and other current assets   1,202,189                   1,202,189 
   Decrease in refundable income taxes   394,902                   394,902 
   Decrease in accounts payable and accrued expenses   (678,380)                  (678,380)
   Decrease in contract liabilities   (1,968,872)                  (1,968,872)
   Decrease in loss reserve   (1,012,597)        1,314,950         302,353 
   Decrease in income taxes payable   (112,777)                  (112,777)
Net cash used in operating activities   (377,982)               (377,982)
Cash flows from investing activities:                         
    Purchase of property and equipment   (436,010)                  (436,010)
Net cash used in investing activities   (436,010)               (436,010)
Cash flows from financing activities:                         
Proceeds from Line of Credit   4,000,000                   4,000,000 
Payments of Line of Credit   (1,300,000)                  (1,300,000)
    Payments on long-term debt   (2,436,786)                  (2,436,786)
Debt issuance costs   (25,000)                  (25,000)
Stock offering costs paid   (119,571)                  (119,571)
Net cash provided by financing activities   118,643                118,643 
Net decrease in cash and restricted cash   (695,349)               (695,349)
                          
Cash and restricted cash at beginning of year   6,128,142                6,128,142 
Cash and restricted cash at end of year  $5,432,793   $   $   $   $5,432,793 
Supplemental schedule of noncash investing activities:                         
Equipment acquired under capital lease  $399,800   $   $   $   $399,800 
Supplemental schedule of cash flow information:                         
Cash paid during the year for interest  $2,066,174   $   $   $   $2,066,174 
Cash (received) from income taxes  $(378,652)  $   $   $   $(378,652)